DaVita Offers Health Economics and Outcomes Research
DaVita Clinical Research (DCR), a provider of clinical research services focused on kidney care as well as a multitude of specialty therapeutic populations, is setting new standards for its Health Economics and Outcomes Research services.
The DCR Health Economics and Outcomes Research team designs and executes studies and economic models and translates the results into tools and products for its customers. By understanding client needs and current trends in the marketplace, DCR has supported access and utilization of multibillion-dollar drug franchises.
DCR’s Health Economics and Outcomes Research services include:
· Strategic consulting
· Economic modeling
· Epidemiology and biostatistics
· Prospective study design, execution, and analysis
· Disease management design, execution, and evaluation
· Psychometric development and validation
· Commercial reimbursement and formulary placement
· Policy analytics and legislative briefings
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
